A medical research company in County Kerry has stared clinical trials of a new drug to find a treatment for Autism Spectrum ...
View the full release here: "As Cognito nears completion of enrollment in our pivotal HOPE trial and prepares for regulatory ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands ...
Health care jobs are among the best-paying because, experts say, the high cost of education and training often involves years ...
Net income of $0.8 millionAdjusted EBITDA1 of $1.3 millionPediatric Portfolio net revenue up 86% sequentiallyFirst quarterly sequential prescription increase for both ADHD and Pediatric portfolios sin ...
Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.
Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...
The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback